Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Benefits versus risks of latest therapies in multiple sclerosis: a perspective review.
Eosinophil pathogenicity mechanisms and therapeutics in neuromyelitis optica.
Characterization of Microcirculation in Multiple Sclerosis Lesions by Dynamic Texture Parameter Analysis (DTPA).
A New Approach for Deep Gray Matter Analysis Using Partial-Volume Estimation.
Comparison of Routine Brain Imaging at 3 T and 7 T.
Utilization of the Expanded Disability Status Scale as a distinctive instrument for walking impairment in persons with multiple sclerosis with mild disability.
Auraptene induces oligodendrocyte lineage precursor cells in a cuprizone-induced animal model of demyelination.
Respiratory training improved ventilatory function and respiratory muscle strength in patients with multiple sclerosis and lateral amyotrophic sclerosis: systematic review and meta-analysis.
Immunomodulation by Sub-Chronic Low Dose 2,3,7,8-Tetrachlorodibenzo-p-dioxin in Experimental Autoimmune Encephalomyelitis in the Absence of Pertussis Toxin.
The cognitive reserve theory in the setting of pediatric-onset multiple sclerosis.
Getting Beyond the Ganglion Cell: Morphometric Adjustments for Retinal Optical Coherence Tomography in Multiple Sclerosis.
Myelination: Actin Disassembly Leads the Way.
IL-27 Induces Th17 Differentiation in the Absence of STAT1 Signaling.
Ocular nerve growth factor administration (oNGF) affects disease severity and inflammatory response in the brain of rats with experimental allergic encephalitis (EAE).
Higher-resolution MR elastography reveals early mechanical signatures of neuroinflammation in patients with clinically isolated syndrome.
Systematic review of clinical practice guidelines related to multiple sclerosis.
Unusual deterioration in a patient with multiple sclerosis on natalizumab therapy.
Urinary trypsin inhibitor levels are reduced in cerebrospinal fluid of multiple sclerosis and neuromyelitis optica patients during relapse.
Cerebral adenosine A1 receptors are upregulated in rodent encephalitis.
Differential neuroprotective effects of 5'-deoxy-5'-methylthioadenosine.
G protein-coupled receptor kinase 2 moderates recruitment of THP-1 cells to the endothelium by limiting histamine-invoked Weibel-Palade body exocytosis.
Multiple sclerosis rebound after fingolimod discontinuation for lymphopenia.
Neuromyelitis optica spectrum disorders without and with autoimmune diseases.
Plaque-like demyelination in acute disseminated encephalomyelitis (ADEM) - an autopsy case report.
Limited TCF7L2 Expression in MS Lesions.
Pages
« first
‹ previous
…
589
590
591
592
593
594
595
596
597
…
next ›
last »